Endocrinology Drugs Market

Endocrinology Drugs Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2031

Endocrinology Drugs Market – Overview

Endocrine drugs are agents coordinated to a failing endocrine way. A few agents are emitted in or focus on the nervous system and are along these lines more inclined to cause neurologic adverse occasions (AEs). The rising adolescent population base which is more inclined to such illnesses because of hormonal irregular characteristics additionally will in general drive the development of the endocrinology drugs market.

Irregular lifestyle habits such as high cholesterol intake, work stress, and weight gain which eventually lead to breaking down of the endocrine system, commencement of new drug delivery systems, broad research and development, and the ascent in extra cash are the key factors boosting the growth of endocrinology drugs market. The quick intake of novel dose structures and definitions of existing drugs is relied upon to expand the quantity of patients for the treatment of endocrine problems subsequently prompting market development. Running against the norm, the unlawful utilization of specific drugs for execution improvement by sports experts represents a danger to society subsequently frustrating the development of the endocrinology drugs market.

The report on the global endocrinology drugs market offers a 360-degree overview of the market factors attributing to its growth or downfall such as drivers, restraints, challenges, and upcoming growth opportunities. It also discusses the impact of the novel COVID19 pandemic on this market and the key strategies adopted by players to attract high revenues during this period. Furthermore, it also provides the list of segments and all players operating in this market with key emphasis on their chief contributions in the form of product launch, and significant collaborations. The report is available for sale on the company website.

Endocrinology Drugs Market – Competitive Landscape

Owing to the presence of multiple players, the nature of the global endocrinology drugs market is highly fragmented. Various companies are indulging themselves in significant collaborations and merger and acquisition strategies for attracting high revenues in the forthcoming years. Other players are making major investments and focusing on the expansion of their geographical outreach to obtain high position in the overall market competition.

Some of the key players of the global endocrinology drugs market include:

  • BHV Pharma
  • Hanmi Pharmaceutical
  • Merck
  • Novo Nordisk
  • KinDex Pharmaceuticals
  • Lee Pharmaceuticals
  • HanAll BioPharma
  • Sanofi
  • Takeda Pharmaceuticals
  • MacroGenics
  • MannKind
  • AstraZeneca
  • VeroScience
  • Endo Pharmaceuticals
  • ChipScreen Biosciences
  • Eli Lily
  • Bayer HealthCare Pharmaceuticals
  • Islet Sciences
  • AbbVie
  • Transition Therapeutics
  • GSK
  • Intrexon
  • Oramed Pharmaceuticals
  • Acerus Pharmaceuticals
  • Other players

Endocrinology Drugs Market – List of Innovations

  •  Food and Drug Administration (FDA) approved drug pipeline in June 2020 for Agios Pharamceuticals Inc. for Mitapivat to be used for treating Thalassemia.

Endocrinology Drugs Market – Growth Drivers

The global endocrinology drugs market is projected to gain impetus during the forecast period owing to the rising commonness of endocrine diseases. These diseases include endocrine glands associated disorders such as Addison’s disease, goiter, acromegaly, gigantism, polycystic ovary syndrome (PCOS), osteomalacia, hypertension, diabetes, hyperlipidemia, thyroiditis, and Cushing’s syndrome. The rising rate of the adolescent population and their vulnerability to diseases caused as a result of hormonal imbalance are likely to help propel the endocrinology drugs market growth in the forecast period.

Endocrinology Drugs Market – Regional Insights

Geographically, North America holds the dominant position in the overall market on account of the rising prevalence of endocrine diseases. Additionally, the presence of a well-established healthcare infrastructure and facilities will also boost the regional growth of this market. The presence of a high adolescent population, coupled with their vulnerability to various diseases will also help this market attract high revenues in the years to come. On the other side, the improving healthcare scenario in the developing nations such as India, China, and others will help Asia Pacific witness the fastest growth rate in the forecast period.



Copyright © Transparency Market Research, Inc. All Rights reserved